Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006678

Options or other derivatives

  • Chief Scientific Officer acquired 687,979 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Dornan David Chief Scientific Officer 2025-03-04 Grant or award · Stock Option (right to buy) +687,979 687,979 D: show line 1 in the form
Loading xslF345X05/form4-03042025_110311.xml…